YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
Body & Mind Incredible progress is being made in health and medicine – every day we seem to broaden our understanding of how to maximize physical and mental health, treat and cure illness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback